Jacobson Pharma board to meet for interim results, dividend consideration

Jacobson Pharma Corporation Limited has announced its board of directors will convene a meeting on Tuesday, November 18, 2025. The primary purpose of this meeting is to review and approve the interim results of the company and its subsidiaries for the six months ending September 30, 2025.

In addition to the financial review, the board will consider the payment of an interim dividend, if any, and address any other business matters. This announcement was made in Hong Kong on November 5, 2025, by Yu Chun Kau, the company secretary, on behalf of the board.

The board of Jacobson Pharma comprises Mr. Sum Kwong Yip, Derek (chairman and chief executive officer), Mr. Yim Chun Leung and Ms. Pun Yue Wai as executive directors, Professor Wong Chi Kei, Ian as non-executive director, and Dr. Lam Kwing Tong, Alan, Mr. Young Chun Man, Kenneth and Mr. Luk Ting Lung, Alan as independent non-executive directors.